Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pilot Study of Pirfenidone in Pulmonary Fibrosis With Anti-myeloperoxydase Antibodies (PIRFENIVAS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03385668
Recruitment Status : Completed
First Posted : December 28, 2017
Last Update Posted : May 3, 2021
Sponsor:
Collaborator:
Roche Pharma AG
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris